At 1.74x price-to-book, CBNK is priced below the 1.82x of Bankwell and well below the 2.25 PEG-implied growth premium some peers command, which suggests investors are discounting the recent volatility in earnings rather than the balance sheet itself. The implied return on tangible equity needed to justify this multiple is roughly in the low double digits, while trailing ROE of about 3% to 4% in recent quarters falls short of that bar. Investors should monitor whether the efficiency ratio stabilizes before assuming any re-rating toward peer book multiples.

DuPont decomposition shows a thin net interest margin of about 1.4% combined with a leverage multiple near nine times, so the return is held down primarily by the spread rather than balance sheet structure. Non-interest income contributing around 18% of revenue provides some diversification but has not been large enough to offset the cost base. The gap to peer ROE appears structural rather than purely cyclical, warranting further investigation of the expense base.

A stable margin alongside a sharp efficiency deterioration suggests the swing reflects expense timing or revenue shortfall rather than a change in funding economics. Operating leverage appears negative in the two quarters where the ratio exceeded 90%, meaning non-interest costs consumed nearly all revenue. Whether this reflects one-time items or a persistent cost base expansion cannot be determined from the supplied data and should be monitored.

The stable equity-to-assets ratio, combined with buybacks of up to $8.6M in a single quarter absorbed without visible erosion, suggests the capital base has provided headroom for growth. The supplied data does not include CET1, Tier 1, or total risk-based capital ratios, so regulatory headroom versus minimums cannot be confirmed. Investors should verify risk-weighted capital levels before drawing firm conclusions about capacity for further capital return.